Inhibitors of Bruton's tyrosine kinase
Granted 13 Oct 2015 · 2 office actions
Current assignee: Pharmacyclics · originally AbbVie Inc.
Law firm: Law firm · Log in to unlock
Attorney: Attorney · Log in to unlock
Inventors: Zhengying Pan, Lee Honigberg, Erik Verner · Examiner: Jeffrey H Murray · AU 1624 · TC 1600
Life of the patent
4 dated eventsAbstract
Disclosed herein is a solid oral formulation comprising a therapeutically effective amount of a compound of Formula (A) formulated for release of the compound in the intestine, wherein the compound of Formula (A) has the structure: [structure]
Claims
13 · 1 independent · depth 7Classifications
6 codes- A61K31/519
- A61K9/48
- A01N43/90
- A61K45/06
- A61K31/00
- C07D487/04
Claim changes
SoonSee which claims were amended, added or cancelled during examination, with every added and removed word marked.
The published claims of this patent are not paired with the granted ones in what we hold.
File wrapper
See the full prosecution history — every USPTO and applicant action on this file, in order.
Log in to unlockTerm & fees
See the term timeline — pendency span, in-force span, the maintenance fees paid and both computed expiry dates.
Log in to unlockPriority chain
2 priority documents›Priority documents — 2
| Type | Document | Date |
|---|---|---|
| provisional | US 60826720 | 22 Sep 2006 |
| related publication | US 20140212485 A1 | 31 Jul 2014 |
Validity challenges
See the validity challenges on record — reexaminations, IPRs and PGRs, with their institution decisions and outcomes.
Log in to unlockCitations
See every patent this one cites and every patent that cites it back — publication, assignee, and how each one was found.
Log in to unlock